Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BLENNOW, Kaj")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 212

  • Page / 9
Export

Selection :

  • and

CSF biomarkers for mild cognitive impairment and early Alzheimer's diseaseANDREASEN, Niels; BLENNOW, Kaj.Clinical neurology and neurosurgery. 2005, Vol 107, Num 3, pp 165-173, issn 0303-8467, 9 p.Article

Effect of HMG-CoA reductase inhibitors on β-amyloid peptide levels : Implications for Alzheimer's diseaseHÖGLUND, Kina; BLENNOW, Kaj.CNS drugs. 2007, Vol 21, Num 6, pp 449-462, issn 1172-7047, 14 p.Article

Alzheimer's diseaseBLENNOW, Kaj; DE LEON, Monyj; ZETTERBERG, Henrik et al.Lancet (British edition). 2006, Vol 368, Num 9533, pp 387-403, issn 0140-6736, 17 p.Article

Low cerebrospinal fluid β-amyloid 42 in patients with acute bacterial meningitis and normalization after treatmentSJÖGREN, Magnus; GISSLEN, Magnus; VANMECHELEN, Eugeen et al.Neuroscience letters. 2001, Vol 314, Num 1-2, pp 33-36, issn 0304-3940Article

Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsyHOLMBERG, Björn; JOHNELS, Bo; BLENNOW, Kaj et al.Movement disorders. 2003, Vol 18, Num 2, pp 186-190, issn 0885-3185, 5 p.Article

Cerebrospinal fluid phospho-tau, total tau and β-amyloid1-42 in the differentiation between Alzheimer's disease and vascular dementiaNÄGGA, Katarina; GOTTFRIES, Johan; BLENNOW, Kaj et al.Dementia and geriatric cognitive disorders. 2002, Vol 14, Num 4, pp 183-190, issn 1420-8008, 8 p.Article

Association between thyroid hormone levels and monoaminergic neurotransmission during surgeryANCKARSATER, Rolf; ZETTERBERG, Henrik; BLENNOW, Kaj et al.Psychoneuroendocrinology. 2007, Vol 32, Num 8-10, pp 1138-1143, issn 0306-4530, 6 p.Article

Cerebrospinal fluid markers for prediction of Alzheimer's diseaseZETTERBERG, Henrik; WAHLUND, Lars-Olof; BLENNOW, Kaj et al.Neuroscience letters. 2003, Vol 352, Num 1, pp 67-69, issn 0304-3940, 3 p.Article

Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkersJEPPSSON, Anna; ZETTERBERG, Henrik; BLENNOW, Kaj et al.Neurology. 2013, Vol 80, Num 15, pp 1385-1392, issn 0028-3878, 8 p.Article

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fallMATTSSON, Niklas; BLENNOW, Kaj; ZETTERBERG, Henrik et al.Clinical chemistry and laboratory medicine. 2010, Vol 48, Num 5, pp 603-607, issn 1434-6621, 5 p.Article

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistryBLENNOW, Kaj; VANMECHELEN, Eugeen.Brain research bulletin. 2003, Vol 61, Num 3, pp 235-242, issn 0361-9230, 8 p.Conference Paper

Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's DiseaseBLENNOW, Kaj; HAMPEL, Harald; ZETTERBERG, Henrik et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 1, pp 189-201, issn 0893-133X, 13 p.Article

Advances in the detection of Alzheimer's disease: use of cerebrospinal fluid biomarkersSJÖGREN, Magnus; ANDREASEN, Niels; BLENNOW, Kaj et al.Clinica chimica acta. 2003, Vol 332, Num 1-2, pp 1-10, issn 0009-8981, 10 p.Article

Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementiaWALLIN, Anders; SJÖGREN, Magnus; BLENNOW, Kaj et al.Dementia and geriatric cognitive disorders. 2003, Vol 16, Num 4, pp 200-207, issn 1420-8008, 8 p.Article

Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's diseaseDAVIDSSON, Pia; BOGDANOVIC, Nenad; LANNFELT, Lars et al.Dementia and geriatric cognitive disorders. 2001, Vol 12, Num 4, pp 243-250, issn 1420-8008Article

Vitamin B12-B6-Folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairmentLEHMANN, Martin; REGLAND, Björn; BLENNOW, Kaj et al.Dementia and geriatric cognitive disorders. 2003, Vol 16, Num 3, pp 145-150, issn 1420-8008, 6 p.Article

An 18-year follow-up of overweight and risk of Alzheimer diseaseGUSTAFSON, Deborah; ROTHENBERG, Elisabet; BLENNOW, Kaj et al.Archives of internal medicine (1960). 2003, Vol 163, Num 13, pp 1524-1528, issn 0003-9926, 5 p.Article

Platelet monoamine oxidase B in family history positive and family history negative type 1 alcohol-dependent subjectsBERGGREN, Ulf; ERIKSSON, Matts; FAHLKE, Claudia et al.Alcohol and alcoholism (Oxford). 2002, Vol 37, Num 6, pp 577-580, issn 0735-0414, 4 p.Article

Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotypeERIKSSON, Matts; BERGGREN, Ulf; BLENNOW, Kaj et al.Alcohol (Fayetteville, NY). 2001, Vol 24, Num 1, pp 15-23, issn 0741-8329Article

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's DiseaseGERHARDSSON, Lars; BLENNOW, Kaj; LUNDH, Thomas et al.Dementia and geriatric cognitive disorders. 2009, Vol 28, Num 1, pp 88-94, issn 1420-8008, 7 p.Article

Biological correlates of clinical subgroups of Alzheimer's diseaseSJÖGREN, Magnus; WIKKELSÖ, Carsten; ÖSTLING, Svante et al.Dementia and geriatric cognitive disorders. 2002, Vol 14, Num 4, pp 191-197, issn 1420-8008, 7 p.Article

Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression. Possible disease markersMATHE, Aleksander A; AGREN, Hans; WALLIN, Anders et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 1, pp 41-48, issn 0278-5846Article

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderlySTOMRUD, Erik; HANSSON, Oskar; BLENNOW, Kaj et al.Dementia and geriatric cognitive disorders. 2007, Vol 24, Num 2, pp 118-124, issn 1420-8008, 7 p.Article

Unaltered plasma levels of β-Amyloid(1-40) and β-Amyloid(1-42) upon stimulation of human plateletsOLSSON, Annika; VANMECHELEN, Eugeen; VANDERSTICHELE, Hugo et al.Dementia and geriatric cognitive disorders. 2003, Vol 16, Num 2, pp 93-97, issn 1420-8008, 5 p.Article

Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosisJOHANSSON, Anders; LARSSON, Anders; NYGREN, Ingela et al.Neuroreport (Oxford). 2003, Vol 14, Num 14, pp 1867-1869, issn 0959-4965, 3 p.Article

  • Page / 9